Yousif Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.51M Sell
10,465
-284
-3% -$159K 0.06% 289
2026
Q1
$6.04M Sell
10,749
-104
-1% -$66.7K 0.07% 254
2025
Q4
$7.45M Sell
10,853
-322
-3% -$219K 0.08% 223
2025
Q3
$7.14M Sell
11,175
-570
-5% -$346K 0.08% 235
2025
Q2
$6.3M Sell
11,745
-253
-2% -$121K 0.07% 267
2025
Q1
$5.04M Sell
11,998
-22
-0.2% -$9.55K 0.06% 310
2024
Q4
$4.97M Sell
12,020
-537
-4% -$236K 0.05% 323
2024
Q3
$6.34M Sell
12,557
-68
-0.5% -$33K 0.07% 267
2024
Q2
$6.15M Sell
12,625
-283
-2% -$142K 0.07% 263
2024
Q1
$6.97M Sell
12,908
-275
-2% -$150K 0.08% 250
2023
Q4
$7.32M Sell
13,183
-352
-3% -$165K 0.09% 217
2023
Q3
$5.92M Sell
13,535
-235
-2% -$117K 0.08% 251
2023
Q2
$6.92M Buy
13,770
+397
+3% +$190K 0.08% 226
2023
Q1
$6.69M Sell
13,373
-323
-2% -$155K 0.09% 217
2022
Q4
$5.59M Buy
13,696
+788
+6% +$306K 0.07% 273
2022
Q3
$4.21M Sell
12,908
-177
-1% -$65K 0.06% 332
2022
Q2
$4.59M Buy
13,085
+143
+1% +$58.3K 0.06% 317
2022
Q1
$7.08M Buy
12,942
+175
+1% +$92.1K 0.08% 246
2021
Q4
$8.41M Buy
+12,767
New +$8.01M 0.09% 204

Other funds holding IDXX

Yousif Capital Management's IDXX Position: Q2 2026 in Review

Yousif Capital Management reduced its Idexx Laboratories (IDXX) stake by 2.6% in Q2 2026, selling an estimated $159K and leaving 10,465 shares worth $5.51M. The position accounts for 0.06% of the portfolio, ranked #289.

Yousif Capital Management first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.41M in Q4 2021. 286 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Yousif Capital Management held 10,465 shares of Idexx Laboratories worth $5.51M as of Q2 2026.
  • Yousif Capital Management sold 284 Idexx Laboratories shares in Q2 2026, an estimated $159K.
  • Idexx Laboratories made up 0.06% of Yousif Capital Management's portfolio in Q2 2026, its #289 holding.
  • Yousif Capital Management first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Idexx Laboratories position peaked at $8.41M in Q4 2021.
  • 286 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.